Ucla Medical Ctr-Rheumatology is categorized under Universities and Colleges in Los Angeles, CA and active since 2012.
Ucla Medical Ctr-Rheumatology was established in 2012, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Universities and Colleges business, which does work in the B2C market, and is classified as a Universities and Colleges, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Diane J Zalba at the company’s single location by writing to 1000 Veteran Avenue, Los Angeles, California CA 90024 or by phoning (310) 825-7991. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Ucla Medical Ctr-Rheumatology |
Contact Person: | Diane J Zalba |
Address: | 1000 Veteran Avenue, Los Angeles, California 90024 |
Phone Number: | (310) 825-7991 |
Website Address: | ucla.edu |
Annual Revenue (USD): | $5.000.000 to $9.999.999 |
Founded: | 2012 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Universities and Colleges |
SIC Code: | 8221 |
NAICS Code: | 6211110 |
Share This Business: |
Ucla Medical Ctr-Rheumatology was started in 2012 to provide professional Universities and Colleges under the SIC code 8221 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Diane J Zalba for inquiries that concern Ucla Medical Ctr-Rheumatology by calling the company number (310) 825-7991, as your correspondence is most welcome. Additionally, the physical location of the single location of Ucla Medical Ctr-Rheumatology can be found at the coordinates 34.06912,-118.44504 as well as the street address 1000 Veteran Avenue in Los Angeles, California 90024.
For its online presence, you may visit Ucla Medical Ctr-Rheumatology’s website at ucla.edu and engage with its social media outlets through on Twitter and on Facebook.